FREE Case Review (866) 588-0600

New Yasmin Pulmonary Embolism Lawsuit Filed

September 25, 2012 – In what appears to be the latest in a seemingly unending wave of similar litigation, a woman has filed a lawsuit against pharmaceutical giant Bayer and other unnamed defendants for damages associated with her ingestion of the controversial birth control pill Yasmin. Specifically, the plaintiff alleges that as a direct result of her use of Yasmin, she was diagnosed with a life-threatening pulmonary embolism in March 2003. At this time, it has not been determined whether the new case will be added to the Yaz Multidistrict Litigation (MDL), which is currently centralized before U.S. District Judge David R. Herndon in the Southern District of Illinois.

Free Yaz Lawsuit Evaluation: If you or a loved one suffered a pulmonary embolism after taking Yaz, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?

According to the new complaint, Yasmin contains drospirenone, a controversial new ‘fourth generation’ synthetic progestin that has been linked to blood clots and other serious side effects. The plaintiff, Suzannah Marek, alleges that no other birth control pills contain drospirenone, except for a recently approved generic version of Yasmin marketed under the trade name Gianvi. Marek further alleges that drospirenone is new, and that there is not a sufficient amount of research available to support its safe use. Studies conducted prior to its approval by the U.S. Food & Drug Administration (FDA) indicated that drospirenone has certain side effects that are different from traditional second generation progestins, and that the ingredient is potentially more dangerous.

According to Marek’s lawsuit, one possible mechanism of action is that drospirenone has the potential to interact differently with ethinyl estradiol compared to other progestins, such that is does not sufficiently counterbalance the clotting effects of estrogen. The plaintiff states that another possible mechanism of action is that drospirenone causes elevated potassium levels in the blood, a condition known as hyperkalemia, which can lead to abnormal heart rhythms. If left untreated, flow of blood to the heart can be slowed to the point that it permits a clot to form. Blood clots in the heart have the potential to lead to heart attacks, strokes, and pulmonary embolisms.

In April 2012, the FDA ordered Bayer and other manufacturers of drospirenone-based contraceptives to update the blood clot warnings on their drugs’ labels. The administration required the labels to state that researchers have found drospirenone birth control pills may triple the risk for blood clots. Since the FDA’s order, Bayer has indicated that it has agreed to pay out $142 million to settle 651 Yasmin and Yasmin lawsuits.

Do I Have a Yaz Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Yaz lawsuits. We are handling individual litigation nationwide and currently accepting new pulmonary embolism cases in all 50 states.

Free Confidential Case Evaluation: Again, if you developed a blood clot after using Yaz, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition